Home
Conditions
HCC - Hepatocellular Carcinoma

Clinical trial condition

HCC - Hepatocellular Carcinoma

Explore clinical trials studying HCC - Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

72 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

HCC - Hepatocellular Carcinoma trial results

Recruiting

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

NCT07521852

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: MengChao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China

Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

NCT07351669

Conditions: Adenocarcinoma, CT, Carcinoma, +11 more
Locations: Zhongda Hospital Southeast University Nanjing, China

View Trial Details

Recruiting

Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma

NCT07610551

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: No. 777, Xitai Road, Chang'an District, Xi'an City, Shaanxi Province, China Xi’an, Shanxi, China

View Trial Details

Recruiting

Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma

NCT07560488

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

NCT06885879

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT07376707

Conditions: Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Needle-based Percutaneous Ablation of Liver Tumors.

NCT06689670

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Koc University Hospital Topkapı, Istanbul, Turkey (Türkiye)

View Trial Details

Recruiting

Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma

NCT07310173

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

NCT07305428

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Queen Mary Hospital Hong Kong

View Trial Details

Recruiting

The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD

NCT07285850

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai Municipality, China

View Trial Details

HCC - Hepatocellular Carcinoma

HCC - Hepatocellular Carcinoma trial results

Related conditions